Barostim
Cardiovascular Devices

Barostim: Funding & valuation

Barostim: 3 money records, each linked to its source.

Data updated Nov 20, 2026 · Back to the company report

Financials

Revenue of $56.7M in 2025. +10.4% on the year before. Net income −$53.3M.

$56.7MRevenue2025 · +10.4%
−$53.3MNet income2025 · +11.1%
Revenue by yearas filed, with the net income
2025$56.7Mnet income −$53.3M
2024$51.3Mnet income −$60M
2023$39.3Mnet income −$41.2M
2022$22.5Mnet income −$41.4M
2021$13Mnet income −$43.1M
2020$6.1Mnet income −$14.1M
Sources: SEC

Money

Barostim: 3 money records, each linked to its source.

$580kCapital expenditureFY2025
From its filingssec.gov ↗
FY2023FY2024FY2025
Income taxes paid$4k––
Capital expenditure$591k$1.4M$580k
Stock-based compensation$6.3M$19.1M$11.1M
People cost

Barostim filed a median H-1B wage of $101k in 2026.

$101kMedian H-1B wage, 20261 casesSource ↗
Median H-1B wage by role, 2026scale to $101k
Clinical Research Associate II · 1$101k
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".